What is ExaCare?
ExaCare operates as an agentic AI platform specifically engineered for the post-acute care market. The company addresses the inefficiencies inherent in skilled nursing facility admissions by ingesting disparate referral data and surfacing actionable insights. By standardizing the decision-making process, ExaCare enables clinical teams to accelerate patient intake, thereby reducing the time between referral and the commencement of care. This technology serves as a critical infrastructure layer for healthcare providers, transforming manual, error-prone workflows into streamlined, automated operations that enhance both clinical outcomes and facility throughput.
How much funding has ExaCare raised?
ExaCare has raised a total of $30M across 1 funding round:
Series A
$30M
Series A (2025): $30M with participation from Insight Partners, Bienville Capital Management, and Foundation Capital
Key Investors in ExaCare
Insight Partners
Insight Partners is a global venture capital and private equity firm that invests in high-growth software and technology companies. It provides capital and hands-on operational support to help businesses scale from early stage to IPO, focusing on enterprise software, SaaS, and internet platforms.
Bienville Capital Management
Bienville operates as an investment firm delivering asset management and advisory services across public and private markets. It serves institutional investors, family offices, and entrepreneurs by offering tailored investment strategies and portfolio solutions.
Foundation Capital
Foundation Capital is a venture capital firm that partners with bold founders building category-defining technology companies, supporting entrepreneurs from the earliest stages through long-term growth with deep operational and strategic expertise.
What's next for ExaCare?
With the backing of major institutional investors, ExaCare is poised to scale its enterprise software suite and deepen its integration capabilities across the healthcare ecosystem. The strategic roadmap likely involves expanding the platform's predictive analytics features and broadening its footprint within the skilled nursing facility market. As the company transitions from its current growth phase, the focus will remain on enhancing the agentic capabilities of its software to further reduce administrative friction. By maintaining a disciplined approach to product development and market penetration, ExaCare is set to redefine the standard for admissions management in the post-acute care landscape.
See full ExaCare company page
